Predictive Value of the Methicillin-Resistant Staphylococcus aureus Nasal Swab for Methicillin-Resistant Staphylococcus aureus Ventilator-Associated Pneumonia in the Trauma Patient
- PMID: 33872057
- DOI: 10.1089/sur.2020.477
Predictive Value of the Methicillin-Resistant Staphylococcus aureus Nasal Swab for Methicillin-Resistant Staphylococcus aureus Ventilator-Associated Pneumonia in the Trauma Patient
Abstract
Background: Many trauma centers have empiric treatment algorithms for ventilator-associated pneumonia (VAP) treatment prior to culture results that include antibiotic agents for methicillin-resistant Staphylococcus aureus (MRSA) coverage that can have adverse effects. This is the only study to evaluate risk factors and MRSA nasal swabs to risk-stratify trauma patients for MRSA VAP, thereby potentially limiting the need for empiric vancomycin. Patients and Methods: This was a single institution retrospective cohort study. Adult patients admitted to the trauma intensive care unit (ICU) between January 2013 and December 2017 who had a MRSA nasal swab and subsequently met criteria for VAP were included. Demographics, risk factors for MRSA pneumonia, and culture results were collected. Results: A total of 140 patients met inclusion criteria. The negative predictive value (NPV) of MRSA nasal swab at predicting subsequent MRSA pneumonia was 97%. The sensitivity, specificity, and positive predictive value were 50.0%, 96.2%, and 44.4%, respectively. Smokers were more likely to develop MRSA pneumonia, odds ratio: 7.0 (p = 0.02). When considering non-smokers with a negative MRSA nasal swab, NPV was 100%. Conclusions: This is the only study to date that assesses the utility of MRSA nasal swab and risk factor data to guide empiric VAP antibiotic therapy in trauma patients. Smoking was found to be a risk factor for MRSA pneumonia. The use of MRSA nasal swabs in combination with smoking status to guide empiric use of MRSA coverage antibiotic agents is recommended because of a 100% NPV. When utilized, as many as 68% of patients may safely be spared MRSA coverage antibiotic agents and the related adverse effects.
Keywords: PCR nasal swab; empiric antibiotic; methicillin-resistant Staphylococcus aureus; trauma patient; ventilator-associated pneumonia.
Similar articles
-
Methicillin-Resistant Staphylococcus aureus Nasal Swab Is Insufficient to Withhold Empiric Methicillin-Resistant Staphylococcus aureus Pneumonia Coverage in a Trauma Population.J Surg Res. 2023 May;285:45-50. doi: 10.1016/j.jss.2022.12.014. Epub 2023 Jan 12. J Surg Res. 2023. PMID: 36640609
-
Ventilator-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia in a Patient with a Negative MRSA Nasal Swab.Am J Case Rep. 2023 Oct 14;24:e941088. doi: 10.12659/AJCR.941088. Am J Case Rep. 2023. PMID: 37837186 Free PMC article.
-
The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.Infect Control Hosp Epidemiol. 2018 Mar;39(3):290-296. doi: 10.1017/ice.2017.308. Epub 2018 Jan 28. Infect Control Hosp Epidemiol. 2018. PMID: 29374504
-
Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening for MRSA Pneumonia.Ann Pharmacother. 2019 Jun;53(6):627-638. doi: 10.1177/1060028018823027. Epub 2019 Jan 2. Ann Pharmacother. 2019. PMID: 30600697
-
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.Clin Microbiol Infect. 2014 Apr;20 Suppl 4:19-36. doi: 10.1111/1469-0691.12450. Clin Microbiol Infect. 2014. PMID: 24580739 Review.
Cited by
-
Evaluation of the Negative Predictive Value of Methicillin-Resistant Staphylococcus aureus Nasal Swab Screening in the Medical Intensive Care Units and Its Effect on Antibiotic Duration.Infect Drug Resist. 2022 Mar 24;15:1259-1266. doi: 10.2147/IDR.S351832. eCollection 2022. Infect Drug Resist. 2022. PMID: 35355623 Free PMC article.
-
Fever and infections in surgical intensive care: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document.Trauma Surg Acute Care Open. 2024 Jun 3;9(1):e001303. doi: 10.1136/tsaco-2023-001303. eCollection 2024. Trauma Surg Acute Care Open. 2024. PMID: 38835635 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous